Halberd (HALB) Return on Equity ROE from the third quarter 2022 to third quarter and annually, average high and low, overall ranking from Apr 30 2022 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Halberd Corporation  (HALB)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Halberd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Halberd in the third quarter 2022?
Due to the lack of equity, it was not possible to calculate Halberd Corporation's return on equity (ROE) in its third quarter 2022

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Apr 30 2022)
III. Quarter		 (Apr 30 2021)
III. Quarter


Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 0 0 0 0
Return On Equity (TTM) - - - - -
HALB's Total Ranking # # # # #
Equity (TTM) in Millions -1 0 0 0 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to HALB Management Effectiveness >> HALB's 5 Years Annual ROE >> Compare HALB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





HALB Annual Return On Equity




Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to HALB Management Effectiveness >> HALB's 5 Years Annual ROE >> Compare HALB ROE to its Competitors




More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HALB's' Return on Equity at Yahoo Finance
HALB's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HALB's Competitors
Subscribers only: Roe for Halberd's Suppliers
Subscribers only: Return On Equity for HALB's Customers




Companies with similar Return On Equity at Apr 30 2022, within Healthcare Sector ROE
Mettler toledo International Inc   523.14 %
Peak Bio Inc   478.68 %
Lianbio  230.93 %
Biovie Inc   222.13 %
Waters Corporation  215.79 %
Halozyme Therapeutics Inc   202.61 %
Cartesian Therapeutics Inc   200.16 %
Warby Parker Inc   193.86 %
Procept Biorobotics Corporation  170.48 %
Avid Bioservices Inc   156.25 %
Entrada Therapeutics Inc   143.64 %
Moderna Inc   121.86 %
Molecular Templates Inc   110.16 %
Idexx Laboratories Inc  103.69 %
REST EZ Inc.  99.51 %
Vyne Therapeutics Inc   96.49 %
Vir Biotechnology Inc   96.39 %
Ironwood Pharmaceuticals inc   95.21 %
Amgen Inc   95.07 %
Davita Inc   94.90 %
Maravai Lifesciences Holdings Inc   92.72 %
Vicarious Surgical Inc  91.60 %
Journey Medical Corp  89.42 %
Tenet Healthcare Corp  88.75 %
Abbvie Inc   86.23 %
Tivity Health Inc   81.80 %
Sensus Healthcare Inc   77.94 %
Biomx Inc  75.95 %
Eli Lilly And Company  73.77 %
Glucotrack Inc   73.46 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.